Humans have about two pounds of bacteria in the intestines. Probiotic refers to the lactic acid producing strains required for overall health and digestion. The pressures of modern existence make it difficult to maintain a balanced population of normal, healthy microbes. Poor food choices, illness, intestinal inflammation, toxins, even weight gain can cause a tipping point allowing the overgrowth of dangerous species. The logical approach to restoring the balance of intestinal flora is the use of probiotics. However, reports on the survival and effectiveness of these microorganisms in the gastrointestinal tract are controversial. Ingested as viable organisms, these microbes often do not survive the rigors of the gastric environment.
The InVite® Health scientific team has solved this, providing strains of healthy bacteria that survive and thrive. The five strains utilized, have been proven in human clinical trials to colonize, and have also been proven to offer a range of benefits for general health and for the digestive tract.
LactoSpore® is a lactic acid producing bacterial strain from Sabinsa Corporation. This species forms spores, which on activation in the acidic environment of the stomach, can germinate and proliferate in the intestine, produce the favored L form of lactic acid and effectively compete with the problematic bacteria. LactoSpore® has been used in successful clinical trials. A colony forming unit (CFU) represents the number of viable bacterial cells that can colonize and act as progenitors that multiply into many additional flora. 600,000 CFU of LactoSpore is intestinal health insurance. The four additional strains are supplied as two-billion CFU each.
The four additional species have all shown ability to sustain or restore health being especially effective for good digestion according to the results of human clinical trials. They improve bloating, flatulence, occasional gastric distress, nausea, vomiting, diarrhea, and constipation. They are not spore forming bacteria; technology ensures their survival. Pharmachem Laboratories microencapsulation technology uses a lipid system that coats the probiotic powder. The bacteria are released in the lower gastrointestinal tract alive, uninjured and viable.